Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy
Download
Download
DownloadPreview
s41598-020-57610-w.pdf
- Published Version
(3MB)
| Preview
Available under license: Creative Commons Attribution
Export
Timpani, Cara 
ORCID: 0000-0003-4567-4319, Goodman, Craig ORCID: 0000-0002-5874-7743, Stathis, Christos ORCID: 0000-0003-0064-9523, White, Jason D, Mamchaoui, Kamel, Butler-Browne, Gillian, Gueven, Nuri, Hayes, Alan ORCID: 0000-0003-1398-3694 and Rybalka, Emma ORCID: 0000-0002-4854-0036
(2020)
Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy.
Scientific Reports, 10.
ISSN 2045-2322
Dimensions Badge
Altmetric Badge
| Item type | Article |
| URI | https://vuir.vu.edu.au/id/eprint/40234 |
| DOI | 10.1038/s41598-020-57610-w |
| Official URL | https://www.nature.com/articles/s41598-020-57610-w |
| Subjects | Historical > FOR Classification > 0601 Biochemistry and Cell Biology Historical > FOR Classification > 1109 Neurosciences Historical > FOR Classification > 1116 Medical Physiology Current > Division/Research > Institute for Health and Sport |
| Keywords | Duschenne Muscular Dystrophy; muscle; adenylosuccinic acid; purine nucleotide cycle metabolite; metabolism; mice |
| Citations in Scopus | 15 - View on Scopus |
| Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)